Spinning a solution in healthcare from a basic technology requires phased research from basic to translational, pre-clinical and clinical studies, for which Japan has a wholesome ecosystem; GN Corp track record, interviewed for a feature story, sponsored by Government of Japan, published in Bloomberg.
Thoothukudi Medical College Dermatologists unravel a novel solution for Psoriasis Vulgaris using Neu-REFIX Beta glucan jointly with Japanese scientists.
4/7/2024
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm, Sweden 0
